NCT06990178View on ClinicalTrials.gov

Adaptive Neoadjuvant Therapy for Esophageal Cancer

NAEnrolling by invitationINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 1, 2028

Primary Completion Date

March 1, 2028

Study Completion Date

March 31, 2028

Conditions
Esophageal CarcinomaNeoadjuvant Therapy
Interventions
RADIATION

Neoadjuvant concurrent chemoradiotherapy

Non-cCR group will continue with neoadjuvant concurrent chemoradiotherapy (2Gy\*20f) followed by radical surgery

Trial Locations (1)

518116

113 Baohe Road,Longgang District,Shenzhen,China, Shenzhen

All Listed Sponsors
lead

Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

OTHER